Objective: 3,4-Methylenedioxymethamphetamine (MDMA), or ecstasy, is a synthetic drug used recreationally, mainly by young people. It has been suggested that MDMA has a Th cell skewing effect, in which Th1 cell activity is suppressed and Th2 cell activity is increased. Experimental allergic airway inflammation in ovalbumin (OVA)-sensitized rodents is a useful model to study Th2 response; therefore, based on the Th2 skewing effect of MDMA, we studied MDMA in a model of allergic lung inflammation in OVA-sensitized mice. Methods: We evaluated cell trafficking in the bronchoalveolar lavage fluid, blood and bone marrow; cytokine production; L-selectin expression and lung histology. We also investigated the effects of MDMA on tracheal reactivity in vitro and mast cell degranulation. Results: We found that MDMA given prior to OVA challenge in OVA-sensitized mice decreased leukocyte migration into the lung, as revealed by a lower cell count in the bronchoalveolar lavage fluid and lung histologic analysis. We also showed that MDMA decreased expression of both Th2-like cytokines (IL-4, IL-5 and IL-10) and adhesion molecules (L-selectin). Moreover, we showed that the hypothalamus-pituitary-adrenal axis is partially involved in the MDMA-induced reduction in leukocyte migration into the lung. Finally, we showed that MDMA decreased tracheal reactivity to methacholine as well as mast cell degranulation in situ. Conclusions: Thus, we report here that MDMA given prior to OVA challenge in OVA-sensitized allergic mice is able to decrease lung inflammation and airway reactivity and that hypothalamus-pituitary-adrenal axis activation is partially involved. Together, the data strongly suggest an involvement of a neuroimmune mechanism in the effects of MDMA on lung inflammatory response and cell recruitment to the lungs of allergic animals.

1.
Liechti ME, Gamma A, Vollenweider FX: Gender differences in the subjective effects of MDMA. Psychopharmacology (Berl) 2001;154:161–168.
2.
Logan BJ, Laverty R, Sanderson WD, Yee YB: Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. Eur J Pharmacol 1988;152:227–234.
3.
Zemishlany Z, Aizenberg D, Weizman A: Subjective effects of MDMA (‘ecstasy’) on human sexual function. Eur Psychiatry 2001;16:127–130.
4.
Sterk CE, Klein H, Elifson KW: Young adult ecstasy users and multiple sexual partners: understanding the factors underlying this HIV risk practice. J Psychoactive Drugs 2008;40:237–244.
5.
Downing J: The psychological and physiological effects of MDMA on normal volunteers. J Psychoactive Drugs 1986;18:335–340.
6.
Verheyden SL, Henry JA, Curran HV: Acute, sub-acute and long-term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users. Hum Psychopharmacol 2003;18:507–517.
7.
Greene SL, Dargan PI, O’Connor N, Jones AL, Kerins M: Multiple toxicity from 3,4-methylenedioxymethamphetamine (‘ecstasy’). Am J Emerg Med 2003;21:121–124.
8.
O’Shea E, Granados R, Esteban B, Colado MI, Green AR: The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (‘ecstasy’). Neuropharmacology 1998;37:919–926.
9.
Green AR, Mechan AO, Elliott JM, O’Shea E, Colado MI: The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’). Pharmacol Rev 2003;55:463–508.
10.
Granado N, O’Shea E, Bove J, Vila M, Colado MI, Moratalla R: Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice. J Neurochem 2008;107:1102–1112.
11.
de Paula VF, Ribeiro A, Pinheiro ML, Sakai M, Lacava MC, Lapachinske SF, Moreau RL, Palermo-Neto J: Methylenedioxymethamphetamine (ecstasy) decreases neutrophil activity and alters leukocyte distribution in bone marrow, spleen and blood. Neuroimmunomodulation 2009;16:191–200.
12.
Boyle NT, Connor TJ: Methylenedioxymethamphetamine (‘ecstasy’)-induced immunosuppression: a cause for concern? Br J Pharmacol 2010;161:17–32.
13.
Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Lopez CH, Ortuno J, Segura J, Cami J, de la Torre R: Immunomodulating activity of MDMA. Ann NY Acad Sci 2000;914:215–224.
14.
Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Ortuno J, Pujadas M, Bacosi A, Menoyo E, Segura J, de la Torre R: Effects of repeated doses of MDMA (‘ecstasy’) on cell-mediated immune response in humans. Life Sci 2001;69:2931–2941.
15.
Pacifici R, Zuccaro P, Farre M, Poudevida S, Abanades S, Pichini S, Langohr K, Segura J, de la Torre R: Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans. Addiction 2007;102:931–936.
16.
Connor TJ: Methylenedioxymethamphetamine (MDMA, ‘ecstasy’): a stressor on the immune system. Immunology 2004;111:357–367.
17.
Pennock JW, Stegall R, Bubar MJ, Milligan G, Cunningham KA, Bourne N: 3,4-Methylenedioxymethamphetamine increases susceptibility to genital herpes simplex virus infection in mice. J Infect Dis 2009;200:1247–1250.
18.
Connor TJ, Dennedy MC, Harkin A, Kelly JP: Methylenedioxymethamphetamine-induced suppression of interleukin-1beta and tumour necrosis factor-alpha is not mediated by serotonin. Eur J Pharmacol 2001;418:147–152.
19.
Connor TJ, Kelly JP, McGee M, Leonard BE: Methylenedioxymethamphetamine (MDMA; ecstasy) suppresses IL-1beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge. Life Sci 2000;67:1601–1612.
20.
Connor TJ, Harkin A, Kelly JP: Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10. J Pharmacol Exp Ther 2005;312:134–143.
21.
Boyle NT, Connor TJ: MDMA (‘ecstasy’) suppresses the innate IFN-gamma response in vivo: a critical role for the anti-inflammatory cytokine IL-10. Eur J Pharmacol 2007;572:228–238.
22.
Pacifici R, Zuccaro P, Hernandez Lopez C, Pichini S, Di Carlo S, Farre M, Roset PN, Ortuno J, Segura J, Torre RL: Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans. J Pharmacol Exp Ther 2001;296:207–215.
23.
Pacifici R, Pichini S, Zuccaro P, Farre M, Segura M, Ortuno J, Di Carlo S, Bacosi A, Roset PN, Segura J, de la Torre R: Paroxetine inhibits acute effects of 3,4-methylenedioxymethamphetamine on the immune system in humans. J Pharmacol Exp Ther 2004;309:285–292.
24.
Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Ortuno J, Segura J, de la Torre R: Immunomodulating properties of MDMA alone and in combination with alcohol: a pilot study. Life Sci 1999;65:PL309–PL316.
25.
Kucharewicz I, Bodzenta-Lukaszyk A, Buczko W: Experimental asthma in rats. Pharmacol Rep 2008;60:783–788.
26.
Lacava M, Ferraz-de-Paula V, Lapachinske SF, Palermo-Neto J, Moreau RLM: Simultaneous determination of methylenedioxymethamphetamine (MDMA) and methylenedioxyamphetamine (MDA) in plasma by gas chromatography with nitrogen-phosphorus detection (GC-NPD) and in vitro effects on the neutrophil activity of mice. Bogotá, III Encuentro Regional de Toxicologia Forense, TIAFT, 2007, pp 97–104.
27.
Ligeiro-Oliveira AP, Fialho de Araujo AM, Lazzarini R, Silva ZL, De Nucci G, Muscara MN, Tavares de Lima W, Palermo-Neto J: Effects of amphetamine on immune-mediated lung inflammatory response in rats. Neuroimmunomodulation 2004;11:181–190.
28.
Proust B, Nahori MA, Ruffie C, Lefort J, Vargaftig BB: Persistence of bronchopulmonary hyper-reactivity and eosinophilic lung inflammation after anti-IL-5 or -IL-13 treatment in allergic Balb/c and IL-4ralpha knockout mice. Clin Exp Allergy 2003;33:119–131.
29.
Massoco C, Palermo-Neto J: Effects of midazolam on equine innate immune response: a flow cytometric study. Vet Immunol Immunopathol 2003;95:11–19.
30.
de Lima WT, da Silva ZL: Contractile responses of proximal and distal trachea segments isolated from rats subjected to immunological stimulation: role of connective tissue mast cells. Gen Pharmacol 1998;30:689–695.
31.
van Rossum J, van den Brink F: Cumulative dose-response curves. 1. Introduction to the technique. Arch Int Pharmacodyn Ther 1963;143:240–246.
32.
Finkelman FD, Hogan SP, Hershey GK, Rothenberg ME, Wills-Karp M: Importance of cytokines in murine allergic airway disease and human asthma. J Immunol 2010;184:1663–1674.
33.
Busse WW, Lemanske RF Jr: Asthma. N Engl J Med 2001;344:350–362.
34.
Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C, Azzarone B: Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest 1998;101:2129–2139.
35.
Cotran RS, Mayadas-Norton T: Endothelial adhesion molecules in health and disease. Pathol Biol (Paris) 1998;46:164–170.
36.
Lloyd CM, Hessel EM: Functions of T cells in asthma: more than just T(h)2 cells. Nat Rev Immunol 2010;10:838–848.
37.
Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM: Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720–1745.
38.
Rothenberg ME: Eosinophilia. N Engl J Med 1998;338:1592–1600.
39.
Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J: Biology of interleukin-10. Cytokine Growth Factor Rev 2010;21:331–344.
40.
Maddox L, Schwartz DA: The pathophysiology of asthma. Annu Rev Med 2002;53:477–498.
41.
Righi DA, Palermo-Neto J: Behavioral effects of type II pyrethroid cyhalothrin in rats. Toxicol Appl Pharmacol 2003;191:167–176.
42.
Righi DA, Palermo-Neto J: Effects of type II pyrethroid cyhalothrin on peritoneal macrophage activity in rats. Toxicology 2005;212:98–106.
43.
Righi DA, Xavier FG, Palermo-Neto J: Effects of type II pyrethroid cyhalothrin on rat innate immunity: a flow cytometric study. Int Immunopharmacol 2009;9:148–152.
44.
Quinteiro-Filho WM, Righi DA, Palermo-Neto J: Effect of cyhalothrin on Ehrlich tumor growth and macrophage activity in mice. Braz J Med Biol Res 2009;42:912–917.
45.
Ligeiro de Oliveira AP, Lazzarini R, Cavriani G, Quinteiro-Filho WM, Tavares de Lima W, Palermo-Neto J: Effects of single or repeated amphetamine treatment and withdrawal on lung allergic inflammation in rats. Int Immunopharmacol 2008;8:1164–1171.
46.
de Oliveira AP, Lino-Dos-Santos-Franco A, Hamasato EK, Quinteiro-Filho W, Hebeda CB, Damazo AS, Farsky SH, Tavares-de-Lima W, Palermo-Neto J: Amphetamine modulates cellular recruitment and airway reactivity in a rat model of allergic lung inflammation. Toxicol Lett 2011;200:117–123.
47.
Cameron L, Hamid Q: Regulation of allergic airways inflammation by cytokines and glucocorticoids. Curr Allergy Asthma Rep 2001;1:153–163.
48.
Liu C, Zhou J, Zhang LD, Wang YX, Kang ZM, Chen YZ, Jiang CL: Rapid inhibitory effect of corticosterone on histamine release from rat peritoneal mast cells. Horm Metab Res 2007;39:273–277.
49.
Zosky GR, Sly PD: Animal models of asthma. Clin Exp Allergy 2007;37:973–988.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.